354
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Molecular dynamic simulation and functional analysis of pathogenic PTEN mutations in glioblastoma

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 11471-11483 | Received 17 Aug 2022, Accepted 20 Dec 2022, Published online: 02 Jan 2023

References

  • Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
  • Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010). A method and server for predicting damaging missense mutations. Nature Methods, 7(4), 248–249. https://doi.org/10.1038/nmeth0410-248
  • Andrews, S. (2010). FastQC: A quality control tool for high throughput sequence data.
  • Ashkenazy, H., Abadi, S., Martz, E., Chay, O., Mayrose, I., Pupko, T., & Ben-Tal, N. (2016). ConSurf 2016: An improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Research, 44(W1), W344–350. https://doi.org/10.1093/nar/gkw408
  • Bassi, C., Ho, J., Srikumar, T., Dowling, R. J., Gorrini, C., Miller, S. J., Mak, T. W., Neel, B. G., Raught, B., & Stambolic, V. (2013). Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress. Science (New York, N.Y.), 341(6144), 395–399. https://doi.org/10.1126/science.1236188
  • Behera, B. K., Parhi, J., Dehury, B., Rout, A. K., Khatei, A., Devi, A. L., & Mandal, S. C. (2022). Molecular characterization and structural dynamics of Aquaporin1 from walking catfish in lipid bilayers. International Journal of Biological Macromolecules, 196, 86–97. https://doi.org/10.1016/j.ijbiomac.2021.12.014
  • Bian, X., Gao, J., Luo, F., Rui, C., Zheng, T., Wang, D., Wang, Y., Roberts, T. M., Liu, P., Zhao, J. J., & Cheng, H. (2018). PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy. Oncogene, 37(3), 341–351. https://doi.org/10.1038/onc.2017.326
  • Brennan, C. W., Verhaak, R. G., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., Beroukhim, R., Bernard, B., Wu, C. J., Genovese, G., Shmulevich, I., Barnholtz-Sloan, J., Zou, L., Vegesna, R., Shukla, S. A., … Chin, L. (2013). The somatic genomic landscape of glioblastoma. Cell, 155(2), 462–477. https://doi.org/10.1016/j.cell.2013.09.034
  • Bromberg, Y., & Rost, B. (2007). SNAP: Predict effect of non-synonymous polymorphisms on function. Nucleic Acids Research, 35(11), 3823–3835. https://doi.org/10.1093/nar/gkm238
  • Capriotti, E., Fariselli, P., & Casadio, R. (2005). I-Mutant2.0: Predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Research, 33(Web Server), W306–310. https://doi.org/10.1093/nar/gki375
  • Cetintas, V. B., & Batada, N. N. (2020). Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment? Journal of Translational Medicine, 18(1), 45. https://doi.org/10.1186/s12967-020-02219-w
  • Choi, S. W., Lee, Y., Shin, K., Koo, H., Kim, D., Sa, J. K., Cho, H. J., Shin, H. M., Lee, S. J., Kim, H., Chung, S., Shin, J., Lee, C., & Nam, D. H. (2021). Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma. Cell Death & Disease, 12(4), 374. https://doi.org/10.1038/s41419-021-03657-0
  • Choi, Y., Sims, G. E., Murphy, S., Miller, J. R., & Chan, A. P. (2012). Predicting the functional effect of amino acid substitutions and indels. PloS One, 7(10), e46688. https://doi.org/10.1371/journal.pone.0046688
  • Colovos, C., & Yeates, T. O. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science: A Publication of the Protein Society, 2(9), 1511–1519. https://doi.org/10.1002/pro.5560020916
  • Costa, H. A., Leitner, M. G., Sos, M. L., Mavrantoni, A., Rychkova, A., Johnson, J. R., Newton, B. W., Yee, M. C., De La Vega, F. M., Ford, J. M., Krogan, N. J., Shokat, K. M., Oliver, D., Halaszovich, C. R., & Bustamante, C. D. (2015). Discovery and functional characterization of a neomorphic PTEN mutation. Proceedings of the National Academy of Sciences of the United States of America, 112(45), 13976–13981. https://doi.org/10.1073/pnas.1422504112
  • Danecek, P., Bonfield, J. K., Liddle, J., Marshall, J., Ohan, V., Pollard, M. O., Whitwham, A., Keane, T., McCarthy, S. A., Davies, R. M., & Li, H. (2021). Twelve years of SAMtools and BCFtools. GigaScience. 10(2), giab008. https://doi.org/10.1093/gigascience/giab008
  • Dono, A., Mitra, S., Shah, M., Takayasu, T., Zhu, J. J., Tandon, N., Patel, C. B., Esquenazi, Y., & Ballester, L. Y. (2021). PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma. Journal of Neuro-Oncology, 153(1), 153–160. https://doi.org/10.1007/s11060-021-03755-1
  • Dunbrack, R. L., Jr., & Karplus, M. (1993). Backbone-dependent rotamer library for proteins. Application to side-chain prediction. Journal of Molecular Biology, 230(2), 543–574. https://doi.org/10.1006/jmbi.1993.1170
  • Ertan, Y., Sezak, M., Demirağ, B., Kantar, M., Cetingül, N., Turhan, T., Erşahin, Y., Mutluer, S., Anacak, Y., & Akalin, T. (2009). Medulloblastoma: Clinicopathologic evaluation of 42 pediatric cases. Child’s Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery, 25(3), 353–356. https://doi.org/10.1007/s00381-008-0784-4
  • Ferguson, S. D., Hodges, T. R., Majd, N. K., Alfaro-Munoz, K., Al-Holou, W. N., Suki, D., de Groot, J. F., Fuller, G. N., Xue, L., Li, M., Jacobs, C., Rao, G., Colen, R. R., Xiu, J., Verhaak, R., Spetzler, D., Khasraw, M., Sawaya, R., Long, J. P., & Heimberger, A. B. (2021). A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram. Neuro-Oncology Advances, 3(1), vdaa146. https://doi.org/10.1093/noajnl/vdaa146
  • Forster, M. D., Dedes, K. J., Sandhu, S., Frentzas, S., Kristeleit, R., Ashworth, A., Poole, C. J., Weigelt, B., Kaye, S. B., & Molife, L. R. (2011). Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nature Reviews Clinical Oncology, 8(5), 302–306. https://doi.org/10.1038/nrclinonc.2011.42
  • George Priya Doss, C., & Rajith, B. (2013). A new insight into structural and functional impact of single-nucleotide polymorphisms in PTEN gene. Cell Biochemistry and Biophysics, 66(2), 249–263. https://doi.org/10.1007/s12013-012-9472-9
  • Gil, A., Rodriguez-Escudero, I., Stumpf, M., Molina, M., Cid, V. J., & Pulido, R. (2015). A functional dissection of PTEN N-terminus: Implications in PTEN subcellular targeting and tumor suppressor activity. PloS One, 10(4), e0119287. https://doi.org/10.1371/journal.pone.0119287
  • Hasle, N., Matreyek, K. A., & Fowler, D. M. (2019). The impact of genetic variants on PTEN molecular functions and cellular phenotypes. Cold Spring Harbor Perspectives in Medicine, 9(11), a036228. https://doi.org/10.1101/cshperspect.a036228
  • Hosseini, K., Ranjbar, M., Pirpour Tazehkand, A., Asgharian, P., Montazersaheb, S., Tarhriz, V., & Ghasemnejad, T. (2022). Evaluation of exosomal non-coding RNAs in cancer using high-throughput sequencing. Journal of Translational Medicine, 20(1), 1–15. https://doi.org/10.1186/s12967-022-03231-y
  • James, C. D., Galanis, E., Frederick, L., Kimmel, D. W., Cunningham, J. M., Atherton-Skaff, P. J., O'Fallon, J. R., Jenkins, R. B., Buckner, J. C., Hunter, S. B., Olson, J. J., & Scheithauer, B. W. (1999). Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation. International Journal of Oncology, 15(3), 547–553. https://doi.org/10.3892/ijo.15.3.547
  • Jang, H., Smith, I. N., Eng, C., & Nussinov, R. (2021). The mechanism of full activation of tumor suppressor PTEN at the phosphoinositide-enriched membrane. iScience, 24(5), 102438. https://doi.org/10.1016/j.isci.2021.102438
  • Kalli, A. C., Devaney, I., & Sansom, M. S. (2014). Interactions of phosphatase and tensin homologue (PTEN) proteins with phosphatidylinositol phosphates: Insights from molecular dynamics simulations of PTEN and voltage sensitive phosphatase. Biochemistry, 53(11), 1724–1732. https://doi.org/10.1021/bi5000299
  • Karn, R., & Emerson, I. A. (2022). Molecular dynamic study on PTEN frameshift mutations in breast cancer provide c2 domain as a potential biomarker. Journal of Biomolecular Structure & Dynamics, 40(7), 3132–3143. https://doi.org/10.1080/07391102.2020.1845802
  • Lee, J.-O., Yang, H., Georgescu, M.-M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., & Pavletich, N. P. (1999). Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell, 99(3), 323–334. https://doi.org/10.1016/s0092-8674(00)81663-3
  • Lee, Y. R., Chen, M., & Pandolfi, P. P. (2018). The functions and regulation of the PTEN tumour suppressor: New modes and prospects. Nature Reviews. Molecular Cell Biology, 19(9), 547–562. https://doi.org/10.1038/s41580-018-0015-0
  • Lopez-Ferrando, V., Gazzo, A., de la Cruz, X., Orozco, M., & Gelpi, J. L. (2017). PMut: A web-based tool for the annotation of pathological variants on proteins, 2017 update. Nucleic Acids Research, 45(W1), W222–W228. https://doi.org/10.1093/nar/gkx313
  • Mansour, W. Y., Tennstedt, P., Volquardsen, J., Oing, C., Kluth, M., Hube-Magg, C., Borgmann, K., Simon, R., Petersen, C., Dikomey, E., & Rothkamm, K. (2018). Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer. Scientific Reports, 8(1), 3947. https://doi.org/10.1038/s41598-018-22289-7
  • McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R., Thormann, A., Flicek, P., & Cunningham, F. (2016). The ensembl variant effect predictor. Genome Biology, 17(1), 1–14. https://doi.org/10.1186/s13059-016-0974-4
  • Mighell, T. L., Evans-Dutson, S., & O'Roak, B. J. (2018). A saturation mutagenesis approach to understanding PTEN lipid phosphatase activity and genotype-phenotype relationships. American Journal of Human Genetics, 102(5), 943–955. https://doi.org/10.1016/j.ajhg.2018.03.018
  • Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., & Tonks, N. K. (1998). The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proceedings of the National Academy of Sciences of the United States of America, 95(23), 13513–13518. https://doi.org/10.1073/pnas.95.23.13513
  • Naderali, E., Khaki, A. A., Rad, J. S., Ali-Hemmati, A., Rahmati, M., & Charoudeh, H. N. (2018). Regulation and modulation of PTEN activity. Molecular Biology Reports, 45(6), 2869–2881. https://doi.org/10.1007/s11033-018-4321-6
  • Nguyen, H. N., Afkari, Y., Senoo, H., Sesaki, H., Devreotes, P. N., & Iijima, M. (2014). Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium. Oncogene, 33(50), 5688–5696. https://doi.org/10.1038/onc.2013.507
  • Papaleo, E., Mereghetti, P., Fantucci, P., Grandori, R., & De Gioia, L. (2009). Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case. Journal of Molecular Graphics & Modelling, 27(8), 889–899. https://doi.org/10.1016/j.jmgm.2009.01.006
  • Parsa, A. T., Waldron, J. S., Panner, A., Crane, C. A., Parney, I. F., Barry, J. J., Cachola, K. E., Murray, J. C., Tihan, T., Jensen, M. C., Mischel, P. S., Stokoe, D., & Pieper, R. O. (2007). Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nature Medicine, 13(1), 84–88. https://doi.org/10.1038/nm1517
  • Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera – A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
  • Plamper, M., Schreiner, F., Gohlke, B., Kionke, J., Korsch, E., Kirkpatrick, J., Born, M., Aretz, S., & Woelfle, J. (2018). Thyroid disease in children and adolescents with PTEN hamartoma tumor syndrome (PHTS). European Journal of Pediatrics, 177(3), 429–435. https://doi.org/10.1007/s00431-017-3067-9
  • Post, K. L., Belmadani, M., Ganguly, P., Meili, F., Dingwall, R., McDiarmid, T. A., Meyers, W. M., Herrington, C., Young, B. P., Callaghan, D. B., Rogic, S., Edwards, M., Niciforovic, A., Cau, A., Rankin, C. H., O'Connor, T. P., Bamji, S. X., Loewen, C. J. R., Allan, D. W., Pavlidis, P., & Haas, K. (2020). Multi-model functionalization of disease-associated PTEN missense mutations identifies multiple molecular mechanisms underlying protein dysfunction. Nature Communications, 11(1), 2073. https://doi.org/10.1038/s41467-020-15943-0
  • Richards, C. S., Bale, S., Bellissimo, D. B., Das, S., Grody, W. W., Hegde, M. R., Lyon, E., & Ward, B. E. (2008). ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genetics in Medicine, 10(4), 294–300. https://doi.org/10.1097/GIM.0b013e31816b5cae
  • Sasaki, H., Zlatescu, M. C., Betensky, R. A., Ino, Y., Cairncross, J. G., & Louis, D. N. (2001). PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. The American Journal of Pathology, 159(1), 359–367. https://doi.org/10.1016/S0002-9440(10)61702-6
  • Schmidt, E. E., Ichimura, K., Goike, H. M., Moshref, A., Liu, L., & Collins, V. P. (1999). Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts. Journal of Neuropathology and Experimental Neurology, 58(11), 1170–1183. https://doi.org/10.1097/00005072-199911000-00007
  • Serrati, S., De Summa, S., Pilato, B., Petriella, D., Lacalamita, R., Tommasi, S., & Pinto, R. (2016). Next-generation sequencing: advances and applications in cancer diagnosis. OncoTargets and Therapy, 9, 7355–7365. https://doi.org/10.2147/OTT.S99807
  • Sittel, F., Jain, A., & Stock, G. (2014). Principal component analysis of molecular dynamics: On the use of Cartesian vs. internal coordinates. The Journal of Chemical Physics, 141(1), 014111. 07B605_601. https://doi.org/10.1063/1.4885338
  • Smith, I. N., & Briggs, J. M. (2016). Structural mutation analysis of PTEN and its genotype-phenotype correlations in endometriosis and cancer. Proteins, 84(11), 1625–1643. https://doi.org/10.1002/prot.25105
  • Smith, I. N., Thacker, S., Jaini, R., & Eng, C. (2019). Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes. Journal of Biomolecular Structure and Dynamics, 37(7), 1766–1782. https://doi.org/10.1080/07391102.2018.1465854
  • Smith, I. N., Thacker, S., Seyfi, M., Cheng, F., & Eng, C. (2019). Conformational dynamics and allosteric regulation landscapes of germline PTEN mutations associated with autism compared to those associated with cancer. American Journal of Human Genetics, 104(5), 861–878. https://doi.org/10.1016/j.ajhg.2019.03.009
  • Vanderver, A., Tonduti, D., Kahn, I., Schmidt, J., Medne, L., Vento, J., Chapman, K. A., Lanpher, B., Pearl, P., Gropman, A., Lourenco, C., Bamforth, J.-S., Sharpe, C., Pineda, M., Schallner, J., Bodamer, O., Orcesi, S., Oberstein, S. A. J. L., Sistermans, E. A., & van der Knaap, M. S. (2014). Characteristic brain magnetic resonance imaging pattern in patients with macrocephaly and PTEN mutations. American Journal of Medical Genetics. Part A, 164A(3), 627–633. https://doi.org/10.1002/ajmg.a.36309
  • Wallner, B., & Elofsson, A. (2003). Can correct protein models be identified? Protein Science: A Publication of the Protein Society, 12(5), 1073–1086. https://doi.org/10.1110/ps.0236803
  • Wang, G., Li, Y., Wang, P., Liang, H., Cui, M., Zhu, M., Guo, L., Su, Q., Sun, Y., McNutt, M. A., & Yin, Y. (2015). PTEN regulates RPA1 and protects DNA replication forks. Cell Research, 25(11), 1189–1204. https://doi.org/10.1038/cr.2015.115
  • Wang, L., Piskorz, A., Bosse, T., Jimenez-Linan, M., Rous, B., Gilks, C. B., Brenton, J. D., Singh, N., & Kobel, M. (2022). Immunohistochemistry and next-generation sequencing are complementary tests in identifying PTEN abnormality in endometrial carcinoma biopsies. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists, 41(1), 12–19. https://doi.org/10.1097/PGP.0000000000000763
  • Webb, B., & Sali, A. (2017). Protein structure modeling with MODELLER. In Functional genomics. (pp. 39–54). Springer.
  • Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35(Web Server), W407–W410.
  • Wong, C. W., Or, P. M. Y., Wang, Y., Li, L., Li, J., Yan, M., Cao, Y., Luk, H. M., Tong, T. M. F., Leslie, N. R., Lo, I. F., Choy, K. W., & Chan, A. M. L. (2018). Identification of a PTEN mutation with reduced protein stability, phosphatase activity, and nuclear localization in Hong Kong patients with autistic features, neurodevelopmental delays, and macrocephaly. Autism Research: Official Journal of the International Society for Autism Research, 11(8), 1098–1109. https://doi.org/10.1002/aur.1950
  • Zhao, J., Chen, A. X., Gartrell, R. D., Silverman, A. M., Aparicio, L., Chu, T., Bordbar, D., Shan, D., Samanamud, J., Mahajan, A., Filip, I., Orenbuch, R., Goetz, M., Yamaguchi, J. T., Cloney, M., Horbinski, C., Lukas, R. V., Raizer, J., Rae, A. I., & Rabadan, R. (2019). Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma. Nature Medicine, 25(3), 462–469. https://doi.org/10.1038/s41591-019-0349-y
  • Zhu, P., Li, H., Zhang, A., Li, Z., Zhang, Y., Ren, M., Zhang, Y., & Hou, Y. (2022). MicroRNAs sequencing of plasma exosomes derived from patients with atrial fibrillation: miR-124-3p promotes cardiac fibroblast activation and proliferation by regulating AXIN1. Journal of Physiology and Biochemistry, 78(1), 85–98.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.